Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1039171-10-2

C18H31NO5 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1039171-10-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1039171-10-2 Structure

  • Basic information

    1. Product Name: C18H31NO5
    2. Synonyms:
    3. CAS NO:1039171-10-2
    4. Molecular Formula:
    5. Molecular Weight: 341.448
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1039171-10-2.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C18H31NO5(CAS DataBase Reference)
    10. NIST Chemistry Reference: C18H31NO5(1039171-10-2)
    11. EPA Substance Registry System: C18H31NO5(1039171-10-2)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1039171-10-2(Hazardous Substances Data)

1039171-10-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1039171-10-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,9,1,7 and 1 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1039171-10:
(9*1)+(8*0)+(7*3)+(6*9)+(5*1)+(4*7)+(3*1)+(2*1)+(1*0)=122
122 % 10 = 2
So 1039171-10-2 is a valid CAS Registry Number.

1039171-10-2Relevant articles and documents

MACROCYCLIC INHIBITORS OF HEPATITIS C PROTEASE

-

, (2009/10/09)

The invention provides compounds inhibitory to the Hepatitis C viral protease, compositions and combinations including the compounds, methods of treatment of conditions wherein inhibition of the Hepatitis C viral protease is medically indicated, and metho

MACROCYCLIC HEPATITIS C PROTEASE INHIBITORS

-

Page/Page column 48, (2008/12/07)

The present invention provides novel macrocyclic compounds that mimic peptide substrates of the hepatitis C viral protease and inhibit the viral protease, more particularly as inhibitors of the NS3 serine protease from hepatitis C virus. Methods for synthesis of the compounds are also provided. The compounds find utility as antiviral agents directed at hepatitis C. The invention further provides methods of employing such inhibitors, alone or in combination with other therapeutic agents, to treat hepatitis C infection in a subject in need of such treatment.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1039171-10-2